跳至主要内容
临床试验/NCT04939974
NCT04939974Unknown不适用

Evaluation of the Efficacy of Oral Probiotics Supplementation in Children With Autism Spectrum Disorders (ASDs): a Randomized Double Blind, Placebo Controlled Trial

All India Institute of Medical Sciences, New Delhi0 个研究点目标入组 100 人开始时间: 2021年8月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
主要终点
change in childhood autism rating scale at 24 weeks as compared to baseline

研究概览

简要总结

One suitable probiotic packet will be administered to one group and placebo to another group of autism children and improvement in CARS will be monitored

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
2 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • All children diagnosed with Autistic Spectrum Disorders by DSM 5 criteria
  • Aged: 2-18 years.
  • Normal hearing (clinically or whenever required by Oto-acoustic emission / automated Brainstem evoked response audiometry)
  • Preferably patients from Delhi-NCR or ready to come for follow up -

排除标准

  • On standard treatment and care for more than 12 weeks
  • Received in last 12 weeks or currently on any complementary and/or alternate therapy including dietary therapy
  • Associated chronic systemic illness
  • Known allergy to any component of probiotic supplement

结局指标

主要结局

change in childhood autism rating scale at 24 weeks as compared to baseline

时间窗: 24 weeks

change in childhood autism rating scale at 24 weeks as compared to baseline

次要结局

未报告次要终点

研究者

发起方
All India Institute of Medical Sciences, New Delhi
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sheffali Gulati

Prof

All India Institute of Medical Sciences, New Delhi

相似试验